RecruitingPHASE1, PHASE2NCT05130437
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
Studying Disorder of branched-chain amino acid metabolism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- ModernaTX, Inc.
- Intervention
- mRNA-3927(biological)
- Enrollment
- 50 enrolled
- Eligibility
- 1 years · All sexes
- Timeline
- 2021 – 2031
Study locations (22)
- Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
- University of Stanford Medical Center, Palo Alto, California, United States
- University of Michigan Hospitals, Ann Arbor, Michigan, United States
- Icahn School of Medicine at Mount Sinai, New York, New York, United States
- Duke University Medical System (Duke Health), Durham, North Carolina, United States
- The Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States
- Texas Children's Hospital, Houston, Texas, United States
- Hospital For Sick Children, Toronto, Ontario, Canada
- AP-HM- Hôpital de La Timone, Marseille, France
- Hôpital Necker - Enfants Malades, Paris, France
- Fujita Health University Hospital, Toyoake-shi, Akita, Japan
- Tohoku University Hospital, Sendai, Miyagi, Japan
- Erasmus MC -Dr. Molewaterplein 40, Rotterdam, South Holland, Netherlands
- Universitair Medisch Centrum Utrecht - PPDS, Utrecht, Netherlands
- King Faisal Specialist Hospital & Research Centre, Riyadh, Ar Riya, Saudi Arabia
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05130437 on ClinicalTrials.govOther trials for Disorder of branched-chain amino acid metabolism
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07573059Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US Inc
- ENROLLING BY INVITATIONNANCT06953505At Home Ammonia Monitoring of Inborn Errors of Ammonia MetabolismSequitur Health Corp.
- RECRUITINGNCT05040178An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and PediatricsRECORDATI GROUP
- RECRUITINGPHASE1, PHASE2NCT04159103Open-Label Study of mRNA-3927 in Participants With Propionic AcidemiaModernaTX, Inc.
- RECRUITINGNCT04176523Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods ApproachRECORDATI GROUP
- RECRUITINGNCT02890342Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic AcidemiaNational Human Genome Research Institute (NHGRI)
See all trials for Disorder of branched-chain amino acid metabolism →